Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.09 – $1.50
1% from low
Borrow rate
0.97%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $10.0M | $455.0K |
| Cost of revenue | $0 | $0 | $23.0K | $0 | $0 | $441.0K | $53.9M | $48.7M |
| Gross profit | $0 | $0 | −$23.0K | $0 | $0 | −$441.0K | −$43.9M | −$48.3M |
| Gross margin | — | — | — | — | — | — | -439.4% | -10613.0% |
| R&D | $3.7M | $11.5M | $32.4M | $61.8M | $62.6M | $55.6M | $53.9M | $48.7M |
| Operating income | −$4.3M | −$13.5M | −$45.6M | −$94.5M | −$105.6M | −$83.0M | −$64.5M | −$104.3M |
| EBITDA | $3.0K | −$3.0M | −$45.5M | −$94.1M | −$105.0M | −$82.1M | −$119.8M | −$105.6M |
| Net income | −$4.3M | −$16.5M | −$45.5M | −$94.0M | −$105.6M | −$82.5M | −$119.8M | −$105.6M |
| Net margin | — | — | — | — | — | — | -1198.5% | -23214.1% |
| EPS (diluted) | -0.47 | -1.80 | -3.55 | -4.28 | -4.12 | -2.18 | -1.42 | -0.76 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2M | $-0.43 | $-0.45–$-0.39 | 2 |
| 2027 | $49M | $-0.22 | $-0.39–$-0.05 | 1 |
| 2028 | $65M | $-0.22 | $-0.39–$-0.05 | 1 |
| 2029 | $151M | $-0.07 | $-0.12–$-0.02 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds APLT.
No tracked institution reports a position in APLT as of their last filing.
No one on the platform has traded APLT yet.
| $301M |
| — |
| MISTMilestone Pharmaceuticals Inc. | $1.25 | +0.81% | $107M | — |
| MOLNMolecular Partners AG | $3.86 | +1.58% | $145M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$APLT stock dropped more than 80% after the FDA rejected its lead drug application and raised concerns about missing trial data and dosing errors, leading to a $15 million investor settlement. If you bought or held $APLT in 2024, you may still be able to recover losses from, as late claims are currently being considered: https://11th.com/cases/applied-therapeutics-investor-suit
View on StockTwits ↗The $15 million Applied Therapeutics ($APLT) settlement is moving forward. Here's everything investors need to know to collect their payout Q: What happened? A: Applied Therapeutics ($APLT) has reached a settlement with investors over claims that it misled them about its lead drug candidate by hiding dosing errors and missing trial data, which ultimately led to a failed FDA review. Q: Am I actually eligible? A: If you bought $APLT shares between January 3, 2024, and December 2, 2024 you’re likely eligible. You don’t need to hold the stock still to claim; past losses count Q: How much will I actually get? A: The current estimated payout is $0.48 per share. The final amount depends on how many people file; if fewer people claim, the payout per share can actually increase for those who did Q: When do payouts happen? A: Typically, within 4–9 months after the claim deadline. But the exact timing depends on the court and settlement administration. Q: I missed the deadline. Is it too late? A: Not necessarily! We are currently processing 'Late-but-Valid' claims. The court often accepts these as long as the fund hasn't been distributed yet. Q: Is my data safe with 11th Estate? A: Security is our top priority. We use bank-level encryption and are SOC2-compliant. We only process the trade data required for the court audit, and your personal financial credentials stay private. Q: What is the fee? A: We work on a 20% success fee. We handle the math, the paperwork, and the filing. If you don't get a payout, you don't pay us a cent. Q: How do I start? A: Just click the link below to submit your claim through our secure portal. https://11th.com/cases/applied-therapeutics-investor-suit
View on StockTwits ↗$APLT Missed the Applied Therapeutics settlement? Here's the quick recap: • What happened ? Applied Therapeutics ($APLT) has reached a $15 million settlement with investors over claims that it misled them about its lead drug candidate by hiding dosing errors and missing trial data, which ultimately led to a failed FDA review. • Who may be eligible? Anyone who purchased or acquired $APLT stock between January 3, 2024, and December 2, 2024. • Is it too late to file? The original deadline passed, but late claims are still being accepted and reviewed. If you held $APLT during the class period, it may be worth checking whether you can still file a late claim: https://11th.com/cases/applied-therapeutics-investor-suit
View on StockTwits ↗$APLT nothing but lawssuits now. and a worthless CVR. Hope you rookie investors learned your lesson. avoid scams
View on StockTwits ↗If you missed the deadline, don’t miss this update. You may still be able to recover losses from $APLT, late claims are currently being accepted: https://11th.com/cases/applied-therapeutics-investor-suit
View on StockTwits ↗If you missed the deadline, don’t miss this update. You may still be able to recover losses from $APLT; late claims are currently being accepted: https://11th.com/cases/applied-therapeutics-investor-suit This recovery fund was established after claims that Applied Therapeutics misled investors about its lead drug candidate by hiding dosing errors and missing trial data, which ultimately led to a failed FDA review. Even though the official deadline has passed, the court is still accepting late submissions. Who can apply? If you bought or held $APLT between January 3, 2024, and December 2, 2024, you’re likely eligible even if you already sold your shares.
View on StockTwits ↗If you missed the deadline, don’t miss this update. You may still be able to recover losses from $APLT, late claims are currently being accepted: https://11th.com/cases/applied-therapeutics-investor-suit This recovery fund was established after claims that Applied Therapeutics misled them about its lead drug candidate by hiding dosing errors and missing trial data, which ultimately led to a failed FDA review.Even though the official deadline has passed, the court is still accepting late submissions. Who can apply? If you bought or held $APLT between January 3, 2024, and December 2, 2024,, you’re likely eligible even if you already sold your shares.
View on StockTwits ↗Missed the Applied Therapeutics ($APLT) deadline? You can still file Most investors assume they're out of luck once the date passes, but the $15 million Applied Therapeutics settlement is currently accepting "Late-but-Valid" claims. If you bought shares between January 3, 2024, and December 2, 2024, you still have a chance to seek recovery. Check the details and submit your late claim here: https://11th.com/cases/applied-therapeutics-investor-suit What is this settlement about? This recovery fund was established after claims that Applied Therapeutics misled investors about its lead drug candidate by hiding dosing errors and missing trial data, which ultimately led to a failed FDA review. Even though the official deadline has passed, the court is still accepting late submissions.
View on StockTwits ↗$APLT how's that CVR from APLT working out for you LOSERS? worthless and collecting dust.??? you all bought a scam! Please admit. I was right about everything!
View on StockTwits ↗$APLT deadline is next week and most investors still haven't filed. Applied Therapeutics reached a $15M settlement after being accused of hiding trial deficiencies and misleading investors about FDA readiness. The stock dropped 80% when the truth came out in late 2024. If you were invested between Jan 2024 and Dec 2024, April 8 is your last chance. Check if you qualify 👉 https://11th.com/cases/applied-therapeutics-investor-suit
View on StockTwits ↗$APLT has agreed to settle with investors over claims that it misled them about its lead drug candidate by hiding dosing errors and missing trial data, which led to a failed FDA review. Who’s eligible? Anyone who purchased $APLT shares between January 3, 2024 and December 2, 2024. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.48 — but normally only ~25% of eligible investors file, the effective payout could increase to $1.92. Can I still file? Yes — claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/applied-therapeutics-investor-suit
View on StockTwits ↗$APLT has reached a $15M settlement with $APLT investors over claims that it misled them about its lead drug candidate by hiding dosing errors and missing trial data. The filing deadline is April 8, 2026. If you bought $APLT between January 3, 2024 and December 2, 2024, you can file for payment here: https://11th.com/cases/applied-therapeutics-investor-suit
View on StockTwits ↗$APLT can some body explain what does CVR mean and should i consider all of money is dumped?
View on StockTwits ↗A common question: what about legal fees? Here's how it works: attorney fees in $APLT $15,000,000 settlement are approved separately by the court — and are capped by law. They don't come out of your payout. The fund set aside for investors is exactly that — for investors. If you bought between January 3, 2024, and December 2, 2024, what's waiting for you has nothing to do with what the lawyers earn. Check your eligibility here: https://11th.com/cases/applied-therapeutics-investor-suit
View on StockTwits ↗This settlement has no impact on $APLT's stock price. Applied Therapeutics already reached a $15M agreement with investors. The case is closed. The settlement fund doesn't come from current operations — it comes from a legal process that has already concluded. You can still be a shareholder and file a claim at the same time. They're not mutually exclusive. If you bought between January 3, 2024 and December 2, 2024, check if you qualify: https://11th.com/cases/applied-therapeutics-investor-suit
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.